Medindia

X

Masimo to Report Fourth Quarter and Fiscal Year 2007 Financial Results on February 26, 2008

Wednesday, February 20, 2008 General News J E 4
Advertisement
IRVINE, Calif., Feb. 19 Masimo Corporation(Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Measure-Through Motionand Low Perfusion pulse oximetry, today announced it will release fourthquarter and fiscal year 2007 financial results for the period endedDecember 29, 2007, after the market closes on Tuesday, February 26, 2008.

A conference call to review the results will begin at 2:00 p.m. PT(5:00 p.m. ET) and will be hosted by Joe E. Kiani, Chairman and ChiefExecutive Officer, and Mark P. de Raad, Executive Vice President & ChiefFinancial Officer.

A live web cast of the conference call will be available online from theinvestor relations page of the Company's corporate web site athttp://www.masimo.com. The dial-in numbers are (800) 295-4740 for domesticcallers and (617) 614-3925 for international callers. The reservation numberfor both dial-in numbers is 39491099. After the live web cast, the call willremain available on Masimo's web site through March 26, 2008. In addition, atelephonic replay of the call will be available until March 10, 2008. Thereplay dial-in numbers are (888) 286-8010 for domestic callers and(617) 801-6888 for international callers. Please use reservation code89834871.

About Masimo

Masimo (Nasdaq: MASI) develops innovative monitoring technologies thatsignificantly improve patient care-helping solve "unsolvable" problems. In1995, the company debuted Measure-Through Motion and Low Perfusion pulseoximetry, known as Masimo SET, and with it virtually eliminated false alarmsand increased pulse oximetry's ability to detect life-threatening events. Morethan 100 independent and objective studies demonstrate Masimo SET provides themost trustworthy SpO2 and pulse rate measurements even under the mostdifficult clinical conditions, including patient motion and low peripheralperfusion. In 2005, Masimo introduced Masimo Rainbow SET, a breakthroughnoninvasive blood constituent monitoring platform that can measure many bloodconstituents that previously required invasive procedures. Rainbow SETcontinuously and noninvasively measures carboxyhemoglobin (SpCO(TM)) andmethemoglobin (SpMet(TM)), pleth variability index (PVI(TM)), in addition tooxyhemoglobin (SpO2), perfusion index (PI) and pulse rate, allowing earlydetection and treatment of potentially life-threatening conditions. Founded in1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Costof Care by Taking Noninvasive Monitoring to New Sites and Applications."Additional information about Masimo and its products may be found athttp://www.masimo.com.

Masimo, SET, Signal Extraction Technology, Improving Outcomes and ReducingCost of Care by Taking Noninvasive Monitoring to New Sites and Applications,Rainbow, SpCO, SpMet, PVI and Pulse CO-Oximeter are trademarks or registeredtrademarks of Masimo Corporation.

SOURCE Masimo Corporation
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Nursing Home Workers Strike Over Employer Miscondu...
S
VA Secretary Announces New Walla Walla Facility